For women worldwide, breast cancer is the most common cancer diagnosed and has the highest death toll. With improvements in screening and treatments over the past 50 years, more women are living longer, but the numbers reveal some tough challenges. By Amy Maxmen.
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DEVELOPING COUNT IES

G OWING PAINS
Women in the United States have a roughly 12% chance of developing breast cancer at some point in their life. But that risk increases when breast cancer runs in the family. Hereditary mutations in the tumour-suppressor genes BRCA1 and BRCA2 raise an individual's risks of developing breast cancer to 60% and 85%, respectively. Disregarding heritable factors, the likelihood of breast cancer through the decades is as follows:
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SU VIVAL FACTO S
Many factors in uence a woman's chance of survival, including how early the tumour is detected and the molecular pro le of the tumour. Even so, women diagnosed now are much more likely to survive than women in decades past. Doctors often detect cancer while the tumour resides in the breast alone. So-called localized tumours grant the patient the best prognosis. As the cancer spreads, it often becomes increasingly di cult to cure.
Patients are living longer each decade, because of improvements in surgery, screening, hormone and biologic therapies, and chemotherapies.
By splitting tumours into categories based on their molecular make-up, researchers can target therapies to the patient. Although mortality rates are relatively low for ER+ patients, the total number of breast cancer deaths from this type exceeds those for the HER2+ and triple-negative group, as they are much more common.
1985-94
ADVANCES FO SOME Increased screening and improved therapies have resulted in lower mortality rates in some population segments. But, although the decline is steep for white women, it is more gradual for African-Americans. e reasons range from inadequate access to healthcare services to biological di erences that might re ect genes or environmental exposures.
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BITTE SWEET SUCCESS
e cost of breast cancer is expected to rise as the population ages and patients live longer because of better -and more expensive -drugs. Because breast cancer is highly prevalent, it might have the highest price tag of any cancer by 2020. e chart projects the costs assuming a 2% increase in the initial treatment phase and a 2% increase in the nal year of life.
THE MALE FACTO
Male breast cancer accounts for about 1% of all breast cancers. Although the incidence appears to be increasing, death rates have decreased by 3.3% a year since 2000.
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